Current Topics in Experimental Endocrinology -

Current Topics in Experimental Endocrinology (eBook)

Volume 2
eBook Download: PDF | EPUB
2013 | 1. Auflage
264 Seiten
Elsevier Science (Verlag)
978-1-4832-1734-5 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
54,95 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Current Topics in Experimental Endocrinology
Current Topics in Experimental Endocrinology, Volume 2 covers major developments in the ever-expanding field of endocrinology. The book discusses the progress in cyclic nucleotide research; the hypothalamic control of the anterior pituitary hormone secretion-characterized hypothalamic hypophysiotropic peptides; and the pituitary-ovarian interrelationships in the rat. The text also describes the melatonin and the endocrine role of the pineal organ; the integration of the secretory control mechanisms for insulin, glucagon, and growth hormone; and the biological activity of somatomedin. The chemistry and physiology of parathyroid hormone, calcitonin, and vitamin d; and the physicochemical properties and activities of luteinizing hormone and human chorionic gonadotropin are also encompassed. Endocrinologists, physiologists, and students taking related courses will find the book invaluable.

Front Cover 1
Current Topics in Experimental Endocrinology 4
Copyright Page 5
Table of Contents 6
LIST OF CONTRIBUTORS 10
PREFACE 12
Chapter 1. Recent Progress in Cyclic Nucleotide Research 14
I. Introduction 15
II. Adenylyl Cyclase 17
III. Cyclic Nucleotide Phosphodiesterases 28
IV. Mechanism of Action of Cyclic AMP 36
V. Cyclic GMP 40
VI. Summary 42
References 44
Chapter 2. Hypothalamic Control of Anterior Pituitary Hormone Secretion—Characterized Hypothalamic-Hypophysiotropic Peptides 50
I. Introduction 51
II. Physiology of Hypothalamic-Releasing and Release-Inhibiting Factors Acting on the Anterior Pituitary 51
III. Mechanism of Action of Hypothalamic-Releasing Factors 54
IV. Peripheral Control of Pituitary Secretion 57
V. Thyrotropin-Releasing Factor (TRF) 58
VI. Luteinizing Hormone-Releasing Factor (LRF) 69
VII. Hypothalamic Control of Growth Hormone Secretion 78
VIII. Hypothalamic Control of Melanocyte-Stimulating Hormone (MSH) 80
IX. Concluding Remarks 81
References 81
Chapter 3. Pituitary-Ovarian Interrelationships in the Rat 86
I. Introduction 86
II. Ovarian Regulation of Gonadotropin Secretion 87
III. Ovarian Regulation of Prolactin Secretion 101
IV. Regulation of Corpus Luteum Function 111
References 116
Chapter 4. Melatonin and the Endocrine Role of the Pineal Organ 120
I. Introduction 120
II. Melatonin Biosynthesis 121
III. Melatonin Metabolism 126
IV. Melatonin and Pinealectomy-Induced Endocrine Changes 128
V. Other Possible Sources of Melatonin 134
VI. Conclusions 135
References 136
Chapter 5. Integration of the Secretory Control Mechanisms for Insulin, Glucagon, and Growth Hormone 142
I. Introduction 143
II. Secretory Control Mechanisms 143
III. Mutual and Autoregulation of Secretion of the Three Hormones 148
IV. Metabolic Actions 150
V. Hormonal Response to Meals 153
VI. Hormonal Milieu in Altered Physiological and Pathological States 155
VII. Relative Importance of the Three Hormones in Metabolism 159
VIII. Concluding Remarks 161
References 162
Chapter 6. Somatomedin 168
I. Introduction 169
II. Bioassay of Somatomedin 169
III. Somatomedin Levels in Disorders of Growth 173
IV. Purification of Somatomedin 175
V. Biological Actions of Somatomedin in Vitro 180
VI. Relation between Somatomedin and Other Growth Factors 184
VII. Conclusions 187
References 188
Chapter 7. Parathyroid Hormone, Calcitonin, and Vitamin D 192
I. Introduction 192
II. Parathyroid Hormone 193
III. Calcitonin 196
IV. Vitamin D 200
References 204
Chapter 8. Luteinizing Hormone and Human Chorionic Gonadotropin: Structure and Activity 208
I. Luteinizing Hormone 210
II. Human Chorionic Gonadotropin 236
References 251
SUBJECT INDEX 260

Recent Progress in Cyclic Nucleotide Research


S.J. Strada and G.A. Robison,     Program in Pharmacology, University of Texas Medical School at Houston, Houston, Texas

Publisher Summary


Adenosine 3’, 5’-monophosphate (cyclic AMP) is formed from ATP through the action of adenylyl cyclase, which seems to be an integral component of the cell membrane in most cells. Hormones appear to stimulate the enzyme by interacting with specific receptors on the external surface of the membrane. Calcium is involved in several ways; it is required for cyclase activation by at least one hormone (ACTH), and there is evidence that some hormones can influence calcium transport independently of their effect on cyclise. Fluoride stimulates adenylyl cyclise activity in broken cell preparations of most eukaryotic cells, but so far, this has not led to any important insights into the mechanism of hormonal stimulation. Cyclic AMP is metabolized to 5’-AMP under the catalytic influence of one or more phosphodiesterases. Phosphohpids, ions, and one or more endogenous proteins are involved in regulating phosphodiesterase activity, and cyclic AMP itself appears capable of inducing the formation of at least one isozyme. Most of the physiologically important effects of cyclic AMP in higher forms are the result of protein kinase activation. Cyclic AMP-dependent protein kinases are composed of catalytic and regulatory subunits.

I Introduction


Adenosine 3′,5′-monophosphate (cyclic AMP) was discovered in 1956 in the course of endocrinological research (see Sutherland and Rall, 1960, for an early review). Most of the research on this substance for the next 10 years or so was concerned directly or indirectly with its role as a regulator of differentiated eukaryotic cell function. It was shown first to mediate the hepatic glycogenolytic effect of glucagon and epinephrine, and was eventually recognized as a second messenger mediating many of the effects of a variety of other hormones, including ACTH (adrenocorticotropic hormones), TSH (thyroid-stimulating hormone), vasopressin, luteinizing hormone, MSH (melanocyte-stimulating hormone), and parathyroid hormone. This aspect of the subject has been discussed in a number of recent monographs and review articles (e.g., Robison et al., 1971 a,b; Hardman et al., 1971; Cheung, 1972; Gill, 1972; Major and Kilpatrick, 1972; Greengard et al., 1972a; Sutherland, 1972).

One of the reasons for the slow initial progress in understanding the role of cyclic AMP was that methodology was difficult, but this is no longer the most important limiting factor (Greengard et al., 1972b; Chasin, 1972). Cyclic AMP has now transcended its endocrinological beginning and has been shown to function in almost all animal species, including bacteria and other unicellular organisms. In Escherichia coli and other gram-negative bacteria, cyclic AMP appears to be required for the synthesis of a number of inducible enzymes, and the ability of glucose to suppress cyclic AMP formation appears to account satisfactorily for catabolite repression (Pastan and Perlman, 1972). Cyclic AMP has also been implicated in lysogeny (Hong et al., 1971) and bacterial transformation (Wise et al., 1973). In certain species of cellular slime molds, cyclic AMP appears to be responsible for initiating the aggregation of slime mold amebae, leading to the formation of a multicellular organism (Bonner, 1971).

Evidence has now begun to accumulate to suggest that cyclic AMP may also play an important role during the growth and development of higher organisms. Although data are presently insufficient to define this role precisely, it would appear that in some types of cells reduced levels of cyclic AMP are needed to permit rapid cell division, whereas higher levels are associated with differentiation (Weiss and Strada, 1973). Changes in cyclic AMP during the cell cycle are now being explored (Willingham et al., 1972; Burger et al., 1972), and an important complementary role for cyclic GMP (guanosine 3′,5′-monophosphate) has been suggested (Hadden et al., 1972). It now seems possible that reduced levels of cyclic AMP or perhaps increased levels of cyclic GMP are involved in a number of proliferative disorders, including psoriasis (Voorhees et al., 1972) and certain forms of cancer (Otten et al., 1972). Cyclic nucleotides may also play an important series of roles during the immune response (see, for example, Orange et al., 1971; Parker, 1972; Hadden et al., 1972; Bourne et al., 1973), although it may be some time before these roles become clarified.

It is no longer possible to discuss intelligently all aspects of cyclic nucleotide research in a single review article. Our purpose in this review will be to summarize what is known about the formation, metabolism, and action of cyclic AMP, with major emphasis on eukaryotic cells. In all cells studied, cyclic AMP is formed from ATP through the catalytic influence of adenylyl cyclase, and is metabolized to 5′-AMP under the influence of one or more phosphodiesterases (Fig.1). The intracellular level of cyclic AMP is therefore determined by the rates of these reactions, as well as by the rate at which it is released into the extracellular space. Most of the effects of cyclic AMP are poorly understood, but the glycogenolytic and lipolytic effects have been shown to involve the activation of a protein kinase. This may be the mechanism of many and perhaps most of the physiologically important effects of cyclic AMP in differentiated eukaryotic cells.

Fig. 1 Reactions involved in the formation and metabolism of cyclic AMP.

II Adenylyl Cyclase


A Relation to Hormone Receptors


The particulate nature of hepatic adenylyl cyclase was established by early experiments of Sutherland and Rall and their colleagues (Sutherland and Rall, 1960; Sutherland et al., 1962). Adenylyl cyclase in most eukary-otic cells appears to occur predominantly in the plasma membrane (Davoren and Sutherland, 1963), although significant activity may also occur in other membranous components in some cells, such as the sarcoplasmic reticulum in muscle cells (Levey, 1971a). The ability of glucagon to stimulate hepatic adenylyl cyclase and of ACTH to stimulate the adrenal enzyme led to the idea that the receptors for some hormones might be closely related to adenylyl cyclase (Sutherland and Rall, 1960).

Based on these and other observations, a model was developed according to which the protein component of the adenylyl cyclase system was envisioned as a two-component system embedded in the lipid matrix of the cell membrane (Robison et al., 1967). A regulatory subunit possessing receptors for one or more hormones was postulated to be in contact with the extracellular space, with a catalytic subunit in contact with cytoplasmic ATP. An effective interaction between hormone and receptor on the external surface of the membrane could thus lead to a conformational perturbation leading to a change in catalytic activity on the inner surface of the membrane. A variant of this model postulated a third component, a “transducer” interposed between an external “discriminator” and an internal “amplifier” (Rodbell, 1972). Such models are perhaps best viewed in the light of the fluid mosaic theory of...

Erscheint lt. Verlag 22.10.2013
Sprache englisch
Themenwelt Sachbuch/Ratgeber Gesundheit / Leben / Psychologie Krankheiten / Heilverfahren
Medizin / Pharmazie Medizinische Fachgebiete
ISBN-10 1-4832-1734-5 / 1483217345
ISBN-13 978-1-4832-1734-5 / 9781483217345
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 32,3 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 5,3 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Diagnostik - Epidemiologie - Therapie

von Sebastian Schulz-Stübner; Markus Dettenkofer …

eBook Download (2023)
Springer-Verlag
46,99
Endlich erkennen - richtig behandeln

von Wolfgang Brückle

eBook Download (2024)
Trias (Verlag)
15,99